“What is the ED95 dose of Prilocaine for femoral nerve block using ultrasound?” - MED and femoral nerve block

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2008-008177-57-GB

Enrollment

Registered

2009-07-20

Start date

2009-06-05

Completion date

Unknown

Last updated

2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Citanest 1% Product Name: Prilocaine Hydrochloride Product Code: PL 17901/0118 Pharmaceutical Form: Injection*

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: • ASA 1-3 patients • Age > 18 years • Routine patients presenting for muscle biopsy Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: • ASA > 3 • Age 35 • Patients on sulphonamides, antimalarials • Pregnant woman

Design outcomes

Primary

Measure	Time frame
Main Objective: To find out the ED95 of 1% prilocaine for femoral nerve block using ultrasound.;Secondary Objective: -;Primary end point(s): Assessment of effect of block to cold with an alcohol swab at the motor point of vastus medialis after femoral nerve block. The motor point of vastus medialis will be identified using a nerve stimulator after the femoral nerve block and is usually about 5 cm medial and cephalad to the knee cap. This does not hurt.	—

Measure

Time frame

Main Objective: To find out the ED95 of 1% prilocaine for femoral nerve block using ultrasound.;Secondary Objective: -;Primary end point(s): Assessment of effect of block to cold with an alcohol swab at the motor point of vastus medialis after femoral nerve block. The motor point of vastus medialis will be identified using a nerve stimulator after the femoral nerve block and is usually about 5 cm medial and cephalad to the knee cap. This does not hurt.

—

Countries

United Kingdom

Outcome results